Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease

Published:2008-09-16 Issue:6 Volume:149 Page:380
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Lee Todd A.¹,Pickard A. Simon¹,Au David H.¹,Bartle Brian¹,Weiss Kevin B.¹

Affiliation:

1. From the Hines Veterans Affairs Hospital, Hines, Illinois; Northwestern University Feinberg School of Medicine, Chicago, Illinois; University of Illinois at Chicago, Chicago, Illinois; Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington; and the American Board of Medical Specialties, Evanston, Illinois.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy of inhaled corticosteroids in patients with coronavirus disease 2019: A living review and meta-analysis;PLOS ONE;2023-11-28

2. Design of the Reducing Diagnostic Error to Improve Patient Safety (REDEfINE) in COPD and asthma study: A cluster randomized comparative effectiveness trial;Contemporary Clinical Trials;2022-12

3. Comorbidity in chronic obstructive pulmonary disease and cardiovascular disease;Cardiovascular Therapy and Prevention;2021-05-14

4. Characterising the cardiovascular safety profile of inhaled muscarinic receptor antagonists;Cardiovascular Complications of Respiratory Disorders;2020-06

5. Asthma: Pathophysiology, Current Status, and Therapeutics;Chronic Lung Diseases;2020